Therapeutics for cognitive aging.

TitleTherapeutics for cognitive aging.
Publication TypeJournal Article
Year of Publication2010
AuthorsShineman, DW, Salthouse TA, Launer LJ, Hof PR, Bartzokis G, Kleiman R, Luine V, Buccafusco JJ, Small GW, Aisen PS, Lowe DA, Fillit HM
JournalAnnals of the New York Academy of Sciences
Volume1191 Suppl 1
PaginationE1-15
Date Published2010 Apr
ISSN1749-6632
KeywordsAging, Biological Markers, Brain Chemistry, Clinical Trials as Topic, cognition, Cognition Disorders, Comorbidity, Humans, Myelin Sheath, Neurons, Neurosecretory Systems, Risk Factors
Abstract

This review summarizes the scientific talks presented at the conference "Therapeutics for Cognitive Aging," hosted by the New York Academy of Sciences and the Alzheimer's Drug Discovery Foundation on May 15, 2009. Attended by scientists from industry and academia, as well as by a number of lay people-approximately 200 in all-the conference specifically tackled the many aspects of developing therapeutic interventions for cognitive impairment. Discussion also focused on how to define cognitive aging and whether it should be considered a treatable, tractable disease.

DOI10.1111/j.1541-0420.2011.01736.x
Alternate JournalAnn. N. Y. Acad. Sci.